Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
North Coast is a venture capital firm founded in 2000 and based in Ann Arbor, Michigan. The firm focuses on investing in early-stage technology-driven companies with significant growth potential, particularly in the Midwest. North Coast has established itself as a key player in the venture capital landscape, emphasizing geographic proximity to foster close relationships with entrepreneurs.
As of now, North Coast manages a fund size of $100 million and has a portfolio that includes a variety of companies across sectors such as biotech, healthcare, materials science, and medical devices. The firm has a history of backing entrepreneurs who are building major enterprises in Indiana, Michigan, and Ohio. Notable milestones include successful exits from companies like Advanced Material Process Corporation and Approach Software Corporation, showcasing the firm’s ability to identify and nurture high-potential startups.
North Coast's team consists of experienced professionals who bring a wealth of knowledge and expertise to their investments. The firm operates from two offices in Michigan, allowing them to maintain a strong presence in the local startup ecosystem.
North Coast invests primarily in early-stage opportunities within technology-driven sectors, including biotech, healthcare, materials science, and medical devices. The firm targets seed stage and growth equity investments, with check sizes ranging from $100,000 to $4 million. This investment strategy allows North Coast to support startups at critical stages of their development, providing the necessary capital to fuel growth.
The firm emphasizes geographic focus, primarily investing in North America, particularly the Midwest. This regional concentration enables North Coast to build strong relationships with entrepreneurs and provide tailored support to its portfolio companies. North Coast seeks companies with significant growth potential and a strong technological foundation, often leveraging partnerships with other corporations and venture capital firms to enhance the value of their investments.
North Coast's investment thesis revolves around identifying early-stage companies where technology, market opportunity, and founder capability align. The firm looks for entrepreneurs who demonstrate a clear vision and the ability to execute their business plans effectively.
North Coast has a diverse portfolio that includes several notable companies:
In addition to its active portfolio, North Coast has achieved notable exits, including:
Hugo Braun: Co-Founder of North Coast, Braun has extensive experience in venture capital, having previously co-managed BankAmerica's venture capital portfolio. He has been instrumental in identifying and supporting technology-driven startups.
Lindsay Aspegren: Co-Founder and General Partner, Aspegren has a strong background in venture capital and is actively involved in the firm's investment decisions. He serves as Board Chair for several portfolio companies, including Larky.
Stephanie Schumacher: Administrative and Finance Manager, Schumacher plays a crucial role in managing the firm's operations and financial activities, ensuring smooth functioning and compliance.
To pitch North Coast, founders should send an email to partners@northcoastvc.com. It is recommended to include a concise executive summary, details about the team, and an overview of the market opportunity. While specific application forms or portals are not disclosed, a well-structured pitch deck can significantly enhance the chances of engagement.
Founders should expect a response within a few weeks, but timelines may vary based on the volume of inquiries. Warm introductions are beneficial but not mandatory.
As of September 29, 2022, North Coast participated in a Series D financing round for Delphinus Medical Technologies, a company specializing in advanced ultrasound technology for breast imaging. This investment reflects North Coast's ongoing commitment to supporting innovative healthcare solutions.
In 2022, North Coast also participated in a Series B financing round for Vytalize Health, a healthcare company focused on improving patient outcomes through technology. These investments highlight the firm's focus on early-stage opportunities in the healthcare sector.
What are North Coast's investment criteria?
North Coast primarily invests in early-stage, technology-driven companies within sectors such as biotech, healthcare, materials science, and medical devices. The firm targets seed stage and growth equity opportunities, with check sizes ranging from $100,000 to $4 million.
How can I pitch North Coast?
Founders can reach out to North Coast via email at partners@northcoastvc.com. It is advisable to provide a clear overview of the business model, market opportunity, and team background in the pitch.
What makes North Coast different from other venture capital firms?
North Coast emphasizes geographic proximity, focusing on the Midwest to build strong relationships with entrepreneurs. This allows them to provide tailored support and strategic guidance to their portfolio companies.
What is North Coast's geographic scope?
The firm primarily invests in North America, with a strong focus on the Midwest, particularly in states like Michigan, Indiana, and Ohio.
What is North Coast's post-investment involvement like?
North Coast actively engages with its portfolio companies, providing strategic guidance and leveraging its extensive network to support growth and innovation.
What is the typical decision timeline for investments?
While specific timelines are not disclosed, founders should expect a thorough evaluation process that may take several weeks, depending on the complexity of the opportunity.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.